Protagonist Therapeutics (PTGX) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.6
0.73
2.05
3.37

Details

Expected EPS
-0.5775
Actual EPS
-0.54
Surprise EPS
0.04
Surprise Percent
+6.49%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.54 per share for Q4 2024.

0 Comments

Share your thoughts